PAX stains in hematologic malignancies, a diagnostic pitfall: a comparative study evaluating monoclonal PAX8s, polyclonal PAX2, and PAX5

[1]  P. Ortiz-Romero,et al.  Primary Cutaneous CD 30 + Lymphoproliferative Disorders , 2017 .

[2]  G. Grigoriadis,et al.  PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvement , 2015, BMJ Case Reports.

[3]  M. Hirsch,et al.  PAX8 and PAX5 are differentially expressed in B‐cell and T‐cell lymphomas , 2013, Histopathology.

[4]  N. Ordóñez.  Value of PAX2 Immunostaining in Tumor Diagnosis: A Review and Update , 2012, Advances in anatomic pathology.

[5]  N. Ordóñez.  Value of PAX 8 Immunostaining in Tumor Diagnosis: A Review and Update , 2012, Advances in anatomic pathology.

[6]  K. Takata,et al.  Primary cutaneous CD30 positive T‐cell lymphoproliferative disorders with aberrant expression of PAX5: Report of three cases , 2012, Pathology international.

[7]  L. Medeiros,et al.  N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas , 2012, Modern Pathology.

[8]  L. Truong,et al.  PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study , 2011, Modern Pathology.

[9]  R. Dewar,et al.  Caution in metastatic renal cell carcinoma within lymph nodes: PAX-2 expression is also seen in nodal lymphocytes. , 2011, Archives of pathology & laboratory medicine.

[10]  M. Desouki,et al.  PAX-5: A Valuable Immunohistochemical Marker in the Differential Diagnosis of Lymphoid Neoplasms , 2010, Clinical Medicine & Research.

[11]  A. Tzankov,et al.  Diagnostic Utility of the B-cell Lineage Markers CD20, CD79a, PAX5, and CD19 in Paraffin-embedded Tissues From Lymphoid Neoplasms , 2009, Applied immunohistochemistry & molecular morphology : AIMM.

[12]  M. Eccles,et al.  Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival , 2003, Oncogene.

[13]  J. Delabie,et al.  The Value of Anti-Pax-5 Immunostaining in Routinely Fixed and Paraffin-Embedded Sections: A Novel Pan Pre-B and B-Cell Marker , 2002, The American journal of surgical pathology.

[14]  J. Epstein,et al.  Getting your Pax straight: Pax proteins in development and disease. , 2002, Trends in genetics : TIG.

[15]  P Gruss,et al.  Pax genes and their roles in cell differentiation and development. , 1996, Current opinion in cell biology.

[16]  J. Bogdanowicz,et al.  REPORT OF THREE CASES. , 1963, American journal of diseases of children.